Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC)
Status:
Withdrawn
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This is a pilot phase II study of histology based consolidation chemotherapy in patients with
inoperable stage III Non-Small Cell Lung Cancer (NSCLC) following concurrent
chemo-radiotherapy. Patients with inoperable stage III NSCLC would be treated with standard
concurrent chemo-radiotherapy and subsequently those with non-squamous histology would be
offered 4 cycles of consolidation pemetrexed and those with squamous histology 4 cycles of
consolidation with gemcitabine.